Clinical-evolutive aspects of pulmonary tuberculosis at patients with chronic hepatitis

I. Marincu, L. Negrutiu, C. Oancea, L. Marincu, M. Cornianu, V. Tudorache, R. Neghina (Timisoara, Romania)

Source: Annual Congress 2007 - Tuberculosis
Session: Tuberculosis
Session type: Thematic Poster Session
Number: 672
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Marincu, L. Negrutiu, C. Oancea, L. Marincu, M. Cornianu, V. Tudorache, R. Neghina (Timisoara, Romania). Clinical-evolutive aspects of pulmonary tuberculosis at patients with chronic hepatitis. Eur Respir J 2007; 30: Suppl. 51, 672

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prevention of drug-induced liver injury in patients with pulmonary tuberculosis and chronic hepatitis C
Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation
Year: 2019

Clinical and morphological outcomes of pulmonary tuberculosis concurrent with chronic hepatitis
Source: Eur Respir J 2006; 28: Suppl. 50, 13s
Year: 2006

Results of treatment of patients with pulmonary tuberculosis combined with HIV infection and hepatitis
Source: International Congress 2018 – Tuberculosis comorbidities
Year: 2018

Prevalence and low diagnostics of chronic non-specific pulmonary diseases among pulmonary TB patients
Source: Annual Congress 2007 - Tuberculosis control in the penitentiary and civilian sector
Year: 2007


The prevalence rate of chronic hepatitis B and C among pulmonary TB patients
Source: Annual Congress 2008 - Tuberculosis in immigrants, disadvantaged populations, elderly, HIV-seropositives and in other risk groups
Year: 2008

The psychological type of chronic pulmonary TB patients
Source: Eur Respir J 2001; 18: Suppl. 33, 474s
Year: 2001

Impact of pulmonary tuberculosis infection on chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011

Interstitial lung involvement in patients with chronic HCV hepatitis
Source: Eur Respir J 2006; 28: Suppl. 50, 744s
Year: 2006

The role of hepatitis C virus infections in idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 333s
Year: 2005

A level of an alpha-1-proteinihibitor in patients with chronic bronchitis and lung tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 339s
Year: 2003

The treatment of acute respiratory viral infections in a patients with a chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Fungal, viral and other infections
Year: 2012


Respiratory viral infections in Iranian patients with exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas
Year: 2010

Endobrochites of specific genesis in patients with pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 201s
Year: 2004

Clinical features of chronic pulmonary aspergillosis treated with voriconazole in patients with chronic respiratory disease
Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD
Year: 2008



Prevalence of CNS lesions in patients with pulmonary tuberculosis and HIV infection
Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Year: 2019


Management of tuberculosis in patients with chronic liver dysfunction
Source: Annual Congress 2007 - Clinical tuberculosis
Year: 2007


History of pulmonary tuberculosis was associated with lung microbiome change in patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD
Year: 2020

The clinical flow and efficiency of treatment of pulmonary tuberculosis in patients with chorine organic pasticides and viral hepatitis ‘B‘ markers
Source: Eur Respir J 2004; 24: Suppl. 48, 50s
Year: 2004

Nontuberculous mycobacterial infection in chronic obstructive pulmonary disease
Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice
Year: 2015

The characteristics of mycobacterioses in patients with chronic lung diseases
Source: International Congress 2019 – Airway infection in COPD
Year: 2019